2024.08.02 (금)

  • 구름조금동두천 26.8℃
  • 맑음강릉 31.6℃
  • 구름많음서울 28.8℃
  • 맑음대전 28.2℃
  • 맑음대구 29.0℃
  • 맑음울산 28.2℃
  • 맑음광주 28.0℃
  • 맑음부산 28.1℃
  • 맑음고창 27.5℃
  • 구름조금제주 29.3℃
  • 맑음강화 26.5℃
  • 구름조금보은 26.3℃
  • 구름조금금산 27.0℃
  • 맑음강진군 26.7℃
  • 맑음경주시 27.8℃
  • 구름조금거제 27.8℃
기상청 제공

경제

Quintiles Advances Risk-based Monitoring with the Launch of Data-driven Trial Execution Powered by Infosario™ Clinical

[By NBC-1TV H. J Yook]Quintiles today announced the launch of its comprehensive, fully-integrated Data-driven Trial Execution offering, which leverages the concept of risk-based monitoring to improve clinical trial delivery. While the industry’s current approach to risk-based monitoring focuses solely on clinical trial monitoring, Data-driven Trial Execution combines study start-up, project management, clinical monitoring, data management and analytics to optimize trial conduct while meeting regulatory demands and quality requirements for Good Clinical Practice (GCP).

“Our customers are seeking to manage clinical trials with greater efficiency, seamless execution and predictive insights that enable them to respond faster and make better-informed decisions,” said Paula Brown Stafford, president of Clinical Development at Quintiles. “Data-driven Trial Execution is the first in a series of standardized offerings that Quintiles plans to bring to market, and is our answer to optimized trial execution that has the potential to improve quality while reducing overall trial costs by up to 25 percent.”



배너

관련기사


배너
배너
배너
배너
배너
배너
배너
배너
배너
배너
배너
배너